FDA Alert - Drug Safety Communication: Methylene Blue - Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications

Sent to you from Drugs.com You received this email because you requested to receive drug alerts. Change your notification settings or unsubscribe here.

FDA MedWatch Alert Sent to subscribers of: methylene blue systemic Drug Safety Communication: Methylene Blue - Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications July 26, 2011 Audience: Emergency Medicine, Critical Care Medicine, Psychiatry. ISSUE: FDA has received reports of serious central nervous system (CNS) reactions when the drug methylene blue is given to patients taking psychiatric medications that work through the serotonin system of the brain (serotonergic psychiatric medications). A list of the serotonergic psychiatric medications that can interact with methylene blue can be found in the Drug Safety Communication. Safety information about this potential drug interaction and important drug usage recommendations for emergency and non-emergency situations are being added to the drug labels for serotonergic psychiatric medications. Read more... Get these updates via twitter

Copyright © 2011 Drugs.com. All rights reserved. Change your notification settings or unsubscribe here.